Stock SER SERODUS ASA
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Serodus ASA Stock

Equities

SER

NO0010549801

Biotechnology & Medical Research

Chart Serodus ASA

Dynamic Chart

Press releases Serodus ASA

Serodus : Primary endpoint reached by SER150 Phase 2a study in Diabetic Nephropathy. PU
Serodus : Q&A delisting from Oslo Axess PU
Serodus : Extraordinary general meeting held PU
Serodus : Viggo Harboe Holding 2006 ApS announces results of voluntary offer PU
Serodus : Viggo Harboe Holding 2006 Aps Launces voluntary offer for outstanding shares in Serodus ASA – Acceptance period starting 31 October 2016 PU
More press releases

Managers and Directors - Serodus ASA

Managers TitleAgeSince
Arnstein Gunnestad Endresen CEO
 Chief Executive Officer 71 15-12-31
Henrik Mordhorst DFI
 Director of Finance/CFO - 18-12-31
Members of the board TitleAgeSince
Terri Sebree BRD
 Director/Board Member 66 14-03-31
Viggo Gunnersen Harboe BRD
 Director/Board Member 78 21-12-31
Søren Elmann Ingerslev CHM
 Chairman - 12-12-31
More insiders

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+8.96% 105B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.43% 104B
ARGENX SE Stock argenx SE
+4.40% 22.94B
BIONTECH SE Stock BioNTech SE
-12.15% 22.34B
GENMAB A/S Stock Genmab A/S
-4.36% 19.25B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.98% 17.08B
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.04% 16.96B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.79% 14.16B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+38.61% 12.63B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. SER Stock